Regeneron Pharmaceuticals, Inc. earnings per share and revenue

REGN earnings per share for the last quarter are 12.46 USD whereas the estimation was 11.69 USD which accounts for 6.54% surprise. Company revenue for the same period amounts to 3.72 B USD despite the estimated figure of 3.67 B USD. Estimated earnings per share for the next quarter are 11.30 USD, and revenue is expected to reach 3.76 B USD. Also watch annual changes over time to get a bigger picture of REGN earnings per share and revenue dynamics.